Home 2023

Astellas

Conscious Re-Coupling: M&A Comes Back Surely, If Slowly
Bioprocessing

Conscious Re-Coupling: M&A Comes Back Surely, If Slowly

Alex Philippidis -
0
BPI News: Opening Keynote Offers Hopeful Outlook for Cell and Gene Therapy
Bioprocessing

BPI News: Opening Keynote Offers Hopeful Outlook for Cell and Gene Therapy

Julianna LeMieux, PhD -
0
Astellas to Invest More than €330 Million in New Facility in Ireland
Bioprocessing

Astellas to Invest More than €330 Million in New Facility in Ireland

John Sterling -
0
AI, Cell/Gene Therapy, Precision Medicine Drive Bullish Biotech Investment
Artificial Intelligence

AI, Cell/Gene Therapy, Precision Medicine Drive Bullish Biotech Investment

Alex Philippidis -
22
Astellas to Acquire Iveric Bio for $5.9B, Expanding Eye Disease Pipeline
Drug Discovery

Astellas to Acquire Iveric Bio for $5.9B, Expanding Eye Disease Pipeline

Alex Philippidis -
0
Staying the Course: New CEO, Same Focus for Astellas Gene Therapies
Drug Discovery

Staying the Course: New CEO, Same Focus for Astellas Gene Therapies

Alex Philippidis -
2
StockWatch: Seven Analysts Cut Price Target for Taysha on FDA Advice, Job Cuts
Cancer

StockWatch: Seven Analysts Cut Price Target for Taysha on FDA Advice, Job Cuts

Alex Philippidis -
0
StockWatch: Astellas Hones Gene Therapy Focus with Taysha Stake
Cancer

StockWatch: Astellas Hones Gene Therapy Focus with Taysha Stake

Alex Philippidis -
0
Astellas Raises Gene Therapy Bet with $100M Manufacturing Facility
GEN Edge

Astellas Raises Gene Therapy Bet with $100M Manufacturing Facility

Alex Philippidis -
0
Astellas Weighs Move into Exosomes
GEN Edge

Astellas Weighs Move into Exosomes

Alex Philippidis -
1
123...12Page 1 of 12
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.